J. Mark Jackson - Concepedia

Author

J. Mark Jackson

Also Known As

J JACKSON, J Jackson, J M Jackson, J MARKJACKSON, J Mark Jackson, J. JACKSON, J. Jackson, J. Mark Jackson, J.M. Jackson, J.Mark Jackson

Publications

Citations

H-Index

Concepts

All Affiliations

University of Louisville Galderma (France)Dermatology Specialists Western University University of Louisville Hospital

About

J. Mark Jackson is an author at University of Louisville specializing in medicine, dermatology, and dermatopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	745
2	Allergy	3	3	51
3	Engineering	1	1	47
4	Language Studies	1	1	12
5	American Sign Language	1	1	12

J. Mark Jackson

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Management of Segmental Defects by the Ilizarov Intercalary Bone Transport Method Stuart A. Green, J. Mark Jackson, DAVID M. WALL, Clinical Orthopaedics and Related Research Bone RepairSurgeryBiomedical EngineeringOsteoporosisOrthopaedic Surgery	1992	237
Pyoderma Gangrenosum: An Update Jeffrey P. Callen, J. Mark Jackson Rheumatic Disease Clinics of North America Pyoderma GangrenosumVasculitisHistopathologyPathologyDermatology	2007	171
Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices Alice B. Gottlieb, Philip J. Mease, J. Mark Jackson, Journal of Dermatological Treatment	2006	85
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea Martin Schaller, Lajos Kemény, Blanka Havlíčková, Journal of the American Academy of Dermatology	2019	66
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials. Linda Stein Gold, Leon Kircik, Joseph E. Fowler, PubMed Atopic DermatitisClinical TrialsInflammatory LesionsPapulopustular RosaceaClinical Dermatology	2014	65
Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL. Linda Stein Gold, Jerry Bagel, Mark Lebwohl, PubMed Bsa 5Clinical TherapeuticMedicineClinical TrialsClinical Dermatology	2018	59
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL Study. Bruce Strober, Jerry Bagel, Mark Lebwohl, PubMed Week 16Clinical TrialsPlaque PsoriasisClinical DermatologyModerate Plaque Psoriasis	2017	54
Use of etanercept for psoriatic arthritis in the dermatology clinic: The Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study Alice B. Gottlieb, Leon Kircik, Drore Eisen, Journal of Dermatological Treatment	2006	48
About the mechanism of formation of iron hydroxide fouling layers on reverse osmosis membranes J. Mark Jackson, D. Landolt Desalination Chemical EngineeringEngineeringIron HydroxideEnvironmental EngineeringReverse Osmosis Membranes	1973	47
Young massive star cluster formation in the Galactic Centre is driven by global gravitational collapse of high-mass molecular clouds Ashley T. Barnes, Steven N. Longmore, A. Avison, Monthly Notices of the Royal Astronomical Society	2019	38

Page 1